Abstract
Hepatocellular carcinoma represents one of the serious and common liver diseases that need to be early diagnosed and promptly treated; Hence various researchers have paid great attention to the utility of molecular markers in the diagnosis and/or prognosis of hepatic neoplasms. Our letter focused on summarizing their role as diagnostic/prognostic tools in patients with hepatocellular tumours for a better outcome.Image 1.